News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,366 Results
Type
Article (87550)
Company Profile (827)
Press Release (774970)
Multimedia
Podcasts (179)
Webinars (28)
Section
Business (233106)
Career Advice (4140)
Deals (39813)
Drug Delivery (141)
Drug Development (91287)
Employer Resources (203)
FDA (18301)
Job Trends (17407)
News (397505)
Policy (39931)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (130)
Alliances (56980)
ALS (147)
Alzheimer's disease (1694)
Antibody-drug conjugate (ADC) (269)
Approvals (18342)
Artificial intelligence (517)
Autoimmune disease (107)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (168)
Biotechnology (485)
Bladder cancer (139)
Brain cancer (53)
Breast cancer (533)
Cancer (4201)
Cardiovascular disease (367)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (716)
Cervical cancer (33)
Clinical research (75868)
Collaboration (1459)
Company closure (4)
Compensation (970)
Complete response letters (63)
COVID-19 (2966)
CRISPR (85)
C-suite (632)
Cystic fibrosis (142)
Data (5012)
Decentralized trials (2)
Denatured (65)
Depression (114)
Diabetes (470)
Diagnostics (7114)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (248)
Drug pricing (196)
Drug shortages (36)
Duchenne muscular dystrophy (209)
Earnings (99444)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (133615)
Executive appointments (1000)
FDA (20903)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (17)
Funding (1311)
Gene editing (181)
Generative AI (52)
Gene therapy (570)
GLP-1 (1045)
Government (5396)
Grass and pollen (8)
Guidances (374)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (69)
Immunology and inflammation (258)
Immuno-oncology (22)
Indications (60)
Infectious disease (3219)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (202)
Interviews (816)
IPO (17932)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (643)
Leadership (37)
Legal (10152)
Liver cancer (92)
Longevity (13)
Lung cancer (595)
Lymphoma (289)
Machine learning (33)
Management (66)
Manufacturing (675)
MASH (148)
Medical device (14917)
Medtech (14946)
Mergers & acquisitions (22797)
Metabolic disorders (1209)
Multiple sclerosis (141)
NASH (23)
Neurodegenerative disease (239)
Neuropsychiatric disorders (64)
Neuroscience (2777)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (584)
Opinion (316)
Ovarian cancer (144)
Pain (173)
Pancreatic cancer (180)
Parkinson's disease (248)
Partnered (32)
Patents (434)
Patient recruitment (342)
Peanut (57)
People (66380)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23401)
Phase II (32920)
Phase III (24828)
Pipeline (3023)
Policy (306)
Postmarket research (3554)
Preclinical (10577)
Press Release (72)
Prostate cancer (206)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (717)
Real estate (7423)
Recruiting (79)
Regulatory (28166)
Reports (65)
Research institute (2698)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (77)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1067)
Venture capital (69)
Weight loss (413)
Women's health (63)
Worklife (21)
Date
Today (284)
Last 7 days (1251)
Last 30 days (3580)
Last 365 days (33789)
2025 (28902)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (51090)
Australia (8982)
California (10035)
Canada (2962)
China (957)
Colorado (420)
Connecticut (445)
Delaware (286)
Europe (117448)
Florida (1471)
Georgia (327)
Hawaii (3)
Idaho (67)
Illinois (833)
India (56)
Indiana (492)
Iowa (20)
Japan (339)
Kansas (127)
Kentucky (39)
Louisiana (23)
Maine (80)
Maryland (1335)
Massachusetts (7488)
Michigan (321)
Minnesota (593)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (80)
New Jersey (2766)
New Mexico (32)
New York (2691)
North Carolina (1457)
North Dakota (10)
Northern California (4636)
Ohio (310)
Oklahoma (22)
Oregon (51)
Pennsylvania (2063)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3831)
Tennessee (153)
Texas (1562)
United States (36753)
Utah (301)
Virginia (257)
Washington D.C. (84)
Washington State (855)
West Virginia (4)
Wisconsin (104)
Wyoming (2)
There are 863,366 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025
November 7, 2025
·
3 min read
Press Releases
PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
November 7, 2025
·
5 min read
Press Releases
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 7, 2025
·
12 min read
Press Releases
RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
November 7, 2025
·
9 min read
Press Releases
Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer’s Program
November 7, 2025
·
3 min read
Press Releases
LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates
November 7, 2025
·
12 min read
Press Releases
Celldex Presents Additional Positive Data Demonstrating Barzolvolimab’s Ability to Drive Rapid, Profound and Durable Complete Urticaria Control in Phase 2 Chronic Spontaneous Urticaria (CSU) Study
November 7, 2025
·
9 min read
Press Releases
Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors
November 7, 2025
·
9 min read
Press Releases
Celldex Presents Results from Barzolvolimab Phase 2 Study in Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Demonstrating Sustained Efficacy and Favorable Safety Profile over 20 Week Placebo Controlled Treatment Period; Up to 66% of Patients with ColdU and 49% with SD Obtain Complete Response at Week 20
November 7, 2025
·
9 min read
Press Releases
Sironax Announces Three Abstracts Selected for Presentation at Neuroscience 2025
November 7, 2025
·
1 min read
1 of 86,337
Next
